EPISODE · Nov 28, 2023 · 28 MIN
Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist
from Keeping Current CME
Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)? Credit available for this activity expires: 11/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
Ready to play
Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.